FDA NDA · NDA202278

ZECUITY

Sponsor: TEVA BRANDED PHARM

APPLICATION

NDA202278

TYPE

NDA

ORIGINAL APPROVAL

2013-01-17

LATEST ACTION

2015-08-24

ROUTE

IONTOPHORESIS

DOSAGE FORM

SYSTEM

MARKETING STATUS

Discontinued

Products

ZECUITY · ReferenceDiscontinued

SUMATRIPTAN SUCCINATE EQ 6.5MG BASE/4HR · SYSTEM · IONTOPHORESIS

2015-08-24Manufacturing (CMC) · Supplement 6 · standardAP

2015-04-07Manufacturing (CMC) · Supplement 7 · standardAP

2015-03-16Manufacturing (CMC) · Supplement 3 · standardAP

2014-03-21Labeling · Supplement 2 · standard — Label ↗AP

2014-03-21Labeling · Supplement 1 · standard — Label ↗AP

2014-01-17Manufacturing (CMC) · Supplement 4 · standardAP

2013-01-17Type 3 - New Dosage Form · Original · standard — Label ↗AP

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.